ClinicalTrials.gov
ClinicalTrials.gov Menu

Parvovirus H-1 (ParvOryx) in Patients With Progressive Primary or Recurrent Glioblastoma Multiforme. (ParvOryx01)

The safety and scientific validity of this study is the responsibility of the study sponsor and investigators. Listing a study does not mean it has been evaluated by the U.S. Federal Government. Read our disclaimer for details.
ClinicalTrials.gov Identifier: NCT01301430
Recruitment Status : Completed
First Posted : February 23, 2011
Last Update Posted : December 4, 2015
Sponsor:
Information provided by (Responsible Party):
Oryx GmbH & Co. KG